These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 15541814)

  • 41. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X; Yue P; Chen S; Hu L; Lonial S; Khuri FR; Sun SY
    Cancer Res; 2007 May; 67(10):4981-8. PubMed ID: 17510429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
    Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
    Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
    Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
    Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
    Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
    Ito S; Kawano Y; Katakura H; Takenaka K; Adachi M; Sasaki M; Shimizu K; Ikenaka K; Wada H; Tanaka F
    Lung Cancer; 2006 Jan; 51(1):79-88. PubMed ID: 16225959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
    Ikeguchi M; Kaibara N
    Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of gene Livin transfection affect on the apoptosis in bladder carcinoma cells].
    Liu XK; Liu HB; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):853-5. PubMed ID: 18756993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells.
    Yang CT; Li JM; Weng HH; Li YC; Chen HC; Chen MF
    Cancer Gene Ther; 2010 Feb; 17(2):120-30. PubMed ID: 19730451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survivin mRNA expression in patients with breast cancer.
    Nasu S; Yagihashi A; Izawa A; Saito K; Asanuma K; Nakamura M; Kobayashi D; Okazaki M; Watanabe N
    Anticancer Res; 2002; 22(3):1839-43. PubMed ID: 12168879
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display.
    Manda R; Kohno T; Matsuno Y; Takenoshita S; Kuwano H; Yokota J
    Genomics; 1999 Oct; 61(1):5-14. PubMed ID: 10512675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells.
    Chen W; Wang X; Zhuang J; Zhang L; Lin Y
    Carcinogenesis; 2007 Oct; 28(10):2114-21. PubMed ID: 17548900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.
    Kami K; Doi R; Koizumi M; Toyoda E; Mori T; Ito D; Kawaguchi Y; Fujimoto K; Wada M; Miyatake S; Imamura M
    Surgery; 2005 Aug; 138(2):299-305. PubMed ID: 16153440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
    Safranek J; Pesta M; Holubec L; Kulda V; Dreslerova J; Vrzalova J; Topolcan O; Pesek M; Finek J; Treska V
    Anticancer Res; 2009 Jul; 29(7):2513-7. PubMed ID: 19596921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
    Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Survivin expression is regulated by an epigenetic mechanism for DMBA-induced hamster buccal-pouch squamous-cell carcinomas.
    Chen YK; Hsue SS; Lin LM
    Arch Oral Biol; 2005 Jun; 50(6):593-8. PubMed ID: 15848153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
    Moussa O; Abol-Enein H; Bissada NK; Keane T; Ghoneim MA; Watson DK
    J Urol; 2006 Jun; 175(6):2312-6. PubMed ID: 16697865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silencing Livin gene expression to inhibit proliferation and enhance chemosensitivity in tumor cells.
    Wang R; Lin F; Wang X; Gao P; Dong K; Zou AM; Cheng SY; Wei SH; Zhang HZ
    Cancer Gene Ther; 2008 Jun; 15(6):402-12. PubMed ID: 18340356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
    Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.